<VariationArchive VariationID="2067512" VariationName="NM_016938.5(EFEMP2):c.859dup (p.Cys287fs)" VariationType="Duplication" Accession="VCV002067512" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2118905" VariationID="2067512">
      <GeneList>
        <Gene Symbol="EFEMP2" FullName="EGF containing fibulin extracellular matrix protein 2" GeneID="30008" HGNC_ID="HGNC:3219" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="65866441" stop="65872800" display_start="65866441" display_stop="65872800" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="65633911" stop="65640404" display_start="65633911" display_stop="65640404" Strand="-" />
          </Location>
          <OMIM>604633</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_016938.5(EFEMP2):c.859dup (p.Cys287fs)</Name>
      <CanonicalSPDI>NC_000011.10:65868409:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="65868409" stop="65868410" display_start="65868409" display_stop="65868410" variantLength="1" positionVCF="65868409" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="65635880" stop="65635881" display_start="65635880" display_stop="65635881" variantLength="1" positionVCF="65635880" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>C287fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.65868410dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.65868410dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.65635881dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.65635881dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012304.2" sequenceAccession="NG_012304" sequenceVersion="2" change="g.9525dup">
            <Expression>NG_012304.2:g.9525dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053116.1" sequenceAccession="NG_053116" sequenceVersion="1" change="g.13349dup">
            <Expression>NG_053116.1:g.13349dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016938.5" sequenceAccession="NM_016938" sequenceVersion="5" change="c.859dup" MANESelect="true">
            <Expression>NM_016938.5:c.859dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_058634.4" sequenceAccession="NP_058634" sequenceVersion="4" change="p.Cys287fs">
            <Expression>NP_058634.4:p.Cys287fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037718.2" sequenceAccession="NR_037718" sequenceVersion="2" change="n.984dup">
            <Expression>NR_037718.2:n.984dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_016938.5(EFEMP2):c.859dup (p.Cys287fs) AND Cutis laxa, autosomal recessive, type 1B" Accession="RCV002966485" Version="2">
        <ClassifiedConditionList TraitSetID="7877">
          <ClassifiedCondition DB="MedGen" ID="C3280798">Cutis laxa, autosomal recessive, type 1B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17937443</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7877" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16805" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cutis laxa, autosomal recessive, type 1B</ElementValue>
                <XRef ID="MONDO:0013754" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB</ElementValue>
                <XRef Type="MIM" ID="614437" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604633.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604633.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604633.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604633.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604633.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604633.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604633.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604633.0006" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ARCL1B</ElementValue>
                <XRef Type="MIM" ID="614437" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15804" />
                <XRef ID="15804" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000561718" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553576" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569455" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000323541" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510760" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">EFEMP2-related cutis laxa, or autosomal recessive cutis laxa type 1B (ARCL1B), is characterized by cutis laxa and systemic involvement, most commonly arterial tortuosity, aneurysms, and stenosis; retrognathia; joint laxity; and arachnodactyly. Severity ranges from perinatal lethality as a result of cardiopulmonary failure to manifestations limited to the vascular and craniofacial systems.</Attribute>
                <XRef ID="NBK54467" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">EFEMP2-Related Cutis Laxa</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21563328</ID>
                <ID Source="BookShelf">NBK54467</ID>
              </Citation>
              <XRef ID="90349" DB="Orphanet" />
              <XRef ID="C3280798" DB="MedGen" />
              <XRef ID="MONDO:0013754" DB="MONDO" />
              <XRef Type="MIM" ID="614437" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5968545" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="3100581|MedGen:C3280798" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003281132" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17937443</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Cys287Leufs*2) in the EFEMP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EFEMP2 are known to be pathogenic (PMID: 17937443). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EFEMP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2067512). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EFEMP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.65635880_65635881insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280798" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5968545" TraitType="Disease" MappingType="XRef" MappingValue="C3280798" MappingRef="MedGen">
        <MedGen CUI="C3280798" Name="Cutis laxa, autosomal recessive, type 1B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

